We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12B
AUM Growth
-$622M
Cap. Flow
-$298M
Cap. Flow %
-2.48%
Top 10 Hldgs %
21.36%
Holding
837
New
28
Increased
81
Reduced
101
Closed
16

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$5.83K
2
RY icon
Royal Bank of Canada
RY
+$4.09K
3
RIO icon
Rio Tinto
RIO
+$3.61K
4
AMGN icon
Amgen
AMGN
+$3.58K
5
ARW icon
Arrow Electronics
ARW
+$3.22K

Top Sells

Rank Stock Value
1
EDU icon
New Oriental
EDU
+$35.3M
2
TIF
Tiffany & Co.
TIF
+$27.7M
3
VRNS icon
Varonis Systems
VRNS
+$17.6M
4
OSB
Norbord Inc.
OSB
+$16.7M
5
QEP
QEP RESOURCES, INC.
QEP
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.23%
2 Technology 22.73%
3 Consumer Discretionary 9.47%
4 Financials 7.93%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MNST icon
276
Monster Beverage
MNST
$95.1B
$8.44M 0.07%
189,936
– –
EW icon
277
Edwards Lifesciences
EW
$49.4B
$8.43M 0.07%
96,190
– –
FAST icon
278
Fastenal
FAST
$54.8B
$8.42M 0.07%
359,070
– –
ETSY icon
279
Etsy
ETSY
$8.12B
$8.4M 0.07%
49,152
– –
MDLZ icon
280
Mondelez International
MDLZ
$83.4B
$8.38M 0.07%
149,200
– –
DELL icon
281
Dell
DELL
$239B
$8.36M 0.07%
234,229
– –
MFC icon
282
Manulife Financial
MFC
$73B
$8.31M 0.07%
486,491
– –
MU icon
283
Micron Technology
MU
$835B
$8.31M 0.07%
105,173
-6
-0% -$509
NSC icon
284
Norfolk Southern
NSC
$75.4B
$8.23M 0.07%
36,069
– –
KMB icon
285
Kimberly-Clark
KMB
$37.6B
$8.18M 0.07%
63,142
– –
IMVT icon
286
Immunovant
IMVT
$7.93B
$8.06M 0.07%
181,749
– –
MCO icon
287
Moody's
MCO
$83.7B
$8.05M 0.07%
28,861
– –
FICO icon
288
Fair Isaac
FICO
$31.8B
$8.04M 0.07%
16,389
– –
CNI icon
289
Canadian National Railway
CNI
$78.5B
$8.01M 0.07%
75,955
– –
AZN icon
290
AstraZeneca
AZN
$269B
$7.86M 0.07%
81,792
+58
+0.1% +$5.83K
NVAX icon
291
Novavax
NVAX
$1.21B
$7.77M 0.06%
72,549
– –
GE icon
292
GE Aerospace
GE
$364B
$7.75M 0.06%
149,920
-18
-0% -$1.09K
TD icon
293
Toronto Dominion Bank
TD
$193B
$7.75M 0.06%
142,913
– –
HPQ icon
294
HP
HPQ
$26B
$7.74M 0.06%
327,468
– –
STRO icon
295
Sutro Biopharma
STRO
$386M
$7.68M 0.06%
36,811
– –
MOR
296
DELISTED
MorphoSys AG American Depositary Shares
MOR
$7.66M 0.06%
281,481
-5
-0% -$134
SYK icon
297
Stryker
SYK
$135B
$7.63M 0.06%
32,432
– –
ORA icon
298
Ormat Technologies
ORA
$5.8B
$7.62M 0.06%
87,885
-12
-0% -$1.19K
FIS icon
299
Fidelity National Information Services
FIS
$24.2B
$7.57M 0.06%
55,670
– –
GEN icon
300
Gen Digital
GEN
$16.5B
$7.56M 0.06%
378,597
– –
10 11
12
13 14

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2021 Portfolio in Review

As of Q1 2021, Candriam SCA held 837 positions worth $12B, down 4.9% from $12.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2021 filing shows 28 new, 81 increased, 101 reduced and 16 closed positions. Its largest new stake was Arrow Electronics: 31 shares worth $3K. The largest sale was New Oriental, an estimated $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q1 2021 buy was Arrow Electronics: 31 shares worth $3K.
  • Candriam SCA added most to AstraZeneca in Q1 2021, an estimated $5.83K increase.
  • Candriam SCA's biggest Q1 2021 reduction was New Oriental, cutting an estimated $35.3M.
  • Candriam SCA fully exited Tiffany & Co. in Q1 2021, selling an estimated $27.7M.
  • Candriam SCA's ten largest holdings make up 21% of its $12B portfolio in Q1 2021.
  • Candriam SCA opened 28 new positions and closed 16 in Q1 2021.
  • Candriam SCA's portfolio value fell 4.9% quarter-over-quarter to $12B.

Based on Candriam SCA's 13F filing for Q1 2021, filed 29 Apr 2021.